慢性阻塞性肺病单吸入器三重疗法的比较有效性和安全性:新的用户队列研究
William B Feldman1,2,3, Samy Suissa4, Aaron S Kesselheim5,3
1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02120, USA wbfeldman@bwh.harvard.edu.
BMJ (Clinical research ed.)
|January 11, 2025
概括
与流动-umeclidinium-vilanterol相比,Budesonide-glycopyrrolate-formoterol并没有改善COPD的治疗结果. 由于环境影响,卫生系统可能会考虑促进后者.
科学领域:
- 肺部医学 肺部医学
- 药物治疗 药物治疗
- 现实世界的证据.
背景情况:
- 慢性阻塞性肺病 (COPD) 管理包括吸入疗法.
- 对比不同类型和配方的吸入器对于优化患者护理至关重要.
- 计量剂量吸入器 (MDIs) 和干粉吸入器 (DPIs) 有不同的特点.
研究的目的:
- 在常规COPD护理中,比较布塞尼德-甘酸-形式醇 (每天两次MDI) 与流动-乌克利迪尼-维兰特罗尔 (每天一次DPI) 的有效性和安全性.
- 评估COPD恶化和肺炎住院病例的发生率.
主要方法:
- 一项新的用户队列研究,利用长度商业美国索赔数据.
- 开始任何一种治疗的患者的倾向性得分匹配 (1:1) (2021年1月~2023年9月).
- 主要结局:第一次中度/重度COPD恶化和第一次肺炎住院治疗.
主要成果:
- 分析了20388个匹配的对.
- 布德塞尼德-甘酸-甲醇显示,中度/重度COPD恶化发生率高出9% (HR 1.09).
- 两种疗法之间没有观察到肺炎住院率的显著差异.
结论:
- 与流动-umeclidinium-vilanterol相比,Budesonide-glycopyrrolate-formoterol没有显示出更优异的临床结果.
- 由于MDIs对环境的影响,卫生系统可能会考虑推广fluticasone-umeclidinium-vilanterol.
相关概念视频
01:23Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
01:26COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
217
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
217
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
231
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
231